StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3086% above fair value
$286.01−6.81 (-2.33%)

Close on Nov 18, 2026Market cap $505.41BP/E 80.8Yield 2.33%

AbbVie shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

AbbVie's shares outstanding was 1.77B at Jun 30, 2026. For fiscal 2025 it was 1.77B, up 0.0% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is 1.78B in fiscal 2022.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251.77B0.0%
FY2024Dec 31, 20241.77B0.0%
FY2023Dec 31, 20231.77B-0.3%
FY2022Dec 31, 20221.78B+0.1%
FY2021Dec 31, 20211.78B+6.2%
FY2020Dec 31, 20201.67B+12.7%
FY2019Dec 31, 20191.48B-4.0%
FY2018Dec 31, 20181.55B-3.6%
FY2017Dec 31, 20171.60B-1.7%
FY2016Dec 31, 20161.63B-0.4%
FY2015Dec 31, 20151.64B+1.7%
FY2014Dec 31, 20141.61B+0.4%
FY2013Dec 31, 20131.60B+1.7%
FY2012Dec 31, 20121.58B0.0%
FY2011Dec 31, 20111.58B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20261.77B0.0%
Q1 FY2026Mar 31, 20261.77B+0.1%
Q4 FY2025Dec 31, 20251.78B0.0%
Q3 FY2025Sep 30, 20251.77B0.0%
Q2 FY2025Jun 30, 20251.77B0.0%
Q1 FY2025Mar 31, 20251.77B-0.1%
Q4 FY2024Dec 31, 20241.78B0.0%
Q3 FY2024Sep 30, 20241.77B+0.1%
Q2 FY2024Jun 30, 20241.77B0.0%
Q1 FY2024Mar 31, 20241.77B-0.2%
Q4 FY2023Dec 31, 20231.78B-0.3%
Q3 FY2023Sep 30, 20231.77B-0.3%
Q2 FY2023Jun 30, 20231.77B-0.3%
Q1 FY2023Mar 31, 20231.78B-0.1%
Q4 FY2022Dec 31, 20221.78B+0.1%
Q3 FY2022Sep 30, 20221.78B-0.1%
Q2 FY2022Jun 30, 20221.78B0.0%
Q1 FY2022Mar 31, 20221.78B+0.2%
Q4 FY2021Dec 31, 20211.78B-0.1%
Q3 FY2021Sep 30, 20211.78B+0.2%
Q2 FY2021Jun 30, 20211.78B+7.8%
Q1 FY2021Mar 31, 20211.77B+19.6%
Q4 FY2020Dec 31, 20201.78B+19.8%
Q3 FY2020Sep 30, 20201.77B+19.6%
Q2 FY2020Jun 30, 20201.65B+11.0%
Q1 FY2020Mar 31, 20201.48B+0.1%
Q4 FY2019Dec 31, 20191.49B-0.9%
Q3 FY2019Sep 30, 20191.48B-2.1%
Q2 FY2019Jun 30, 20191.48B-5.6%
Q1 FY2019Mar 31, 20191.48B-7.1%
Q4 FY2018Dec 31, 20181.50B-6.5%
Q3 FY2018Sep 30, 20181.51B-5.5%
Q2 FY2018Jun 30, 20181.57B-1.7%
Q1 FY2018Mar 31, 20181.60B-0.4%
Q4 FY2017Dec 31, 20171.61B-1.2%
Q3 FY2017Sep 30, 20171.60B-2.3%
Q2 FY2017Jun 30, 20171.60B–
Q1 FY2017Mar 31, 20171.60B–
Q4 FY2016Dec 31, 20161.63B–
Q3 FY2016Sep 30, 20161.64B–

More AbbVie figures

See a number that looks wrong?